TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Euroform MediPharm AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,875
|
3,217
|
3,482 |
Financial expenses |
0
|
11
|
39 |
Earnings before taxes |
44
|
-317
|
-1,168 |
EBITDA |
98
|
-231
|
-451 |
Total assets |
2,176
|
2,225
|
2,698 |
Current assets |
1,928
|
1,931
|
2,292 |
Current liabilities |
854
|
845
|
1,152 |
Equity capital |
1,307
|
1,349
|
1,500 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.1%
|
60.6%
|
55.6% |
Turnover per employee |
221
|
247
|
290 |
Profit as a percentage of turnover |
1.5%
|
-9.9%
|
-33.5% |
Return on assets (ROA) |
2.0%
|
-13.8%
|
-41.8% |
Current ratio |
225.8%
|
228.5%
|
199.0% |
Return on equity (ROE) |
3.4%
|
-23.5%
|
-77.9% |
Change turnover |
-352
|
17
|
639 |
Change turnover % |
-11%
|
1%
|
22% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.